THE CHROMOSOME | Clinical Content Series
Vitamin D Deficiency
Back to Case Studies ArchiveCase Study
She was 36 years old and had been tired for so long that she had accepted tiredness as her baseline state. Not the tiredness of a busy day or a poor night, but a pervasive, whole body exhaustion that was present every morning before the day had made any demand on her whatsoever. She ached, her muscles, her bones, her joints, in a diffuse, difficult to localise way that she described as feeling as though her body was made of something heavier than it should be. She had gained 18 kilograms across three years. She was emotionally fragile in ways that felt disproportionate to her circumstances, crying easily, feeling anxious without clear cause, experiencing a low mood that lifted briefly in summer and deepened reliably every winter.
She had seen three physicians. She had been told she was anaemic, she was mildly so, but the anaemia did not explain the totality of what she was experiencing. She had been told she was depressed, she had been prescribed an antidepressant that had made no meaningful difference. She had been told her joint pain was early arthritis, she had been given anti-inflammatory medication that managed the pain without addressing its origin.
Nobody had measured her vitamin D.
When I ordered a comprehensive hormonal and metabolic panel as part of her first assessment, her 25-hydroxyvitamin D level was 7 nanomoles per litre. The lower limit of sufficiency is 75. She was not deficient. She was profoundly, critically depleted, at a level I associate with patients who have had essentially no meaningful vitamin D status for years.
This finding, which should have been shocking, was not shocking to me. It was consistent with what I find in the majority of Pakistani patients I evaluate comprehensively, particularly Pakistani women who cover their skin for cultural and religious reasons, who spend limited time outdoors, whose diet provides minimal vitamin D from food sources, and whose visceral adiposity sequesters whatever vitamin D their limited sun exposure manages to generate. Pakistan is a country of extraordinary sunlight and extraordinary vitamin D deficiency, a paradox that reflects the intersection of cultural practice, dietary pattern, and the biological reality that sunlight alone cannot overcome the combination of coverage, indoor living, and adipose sequestration that characterises the vitamin D status of a substantial proportion of the Pakistani population.
What made her case clinically instructive was the question I asked that her previous physicians had not. Not simply what her vitamin D level was, but what that level was doing to every other hormonal and metabolic system in her body. Because vitamin D is not simply a vitamin. It is a steroid hormone, produced in the skin from cholesterol precursors, transported in the bloodstream, converted to its active form in the kidneys, and acting through nuclear receptors expressed in virtually every tissue and organ in the human body. Its deficiency does not produce a single symptom or a single metabolic consequence. It produces a systemic hormonal disruption that affects immune function, insulin signalling, thyroid activity, parathyroid regulation, muscle function, bone metabolism, mood regulation, cardiovascular health, and the inflammatory environment that governs every other hormonal interaction.
Her insulin resistance was significant, driven in part by vitamin D deficiency, which impairs insulin receptor expression and reduces the pancreatic beta cell's sensitivity to glucose stimulated insulin secretion. Her thyroid antibodies were elevated, reflecting the immune dysregulation that vitamin D deficiency permits by removing one of the most important modulators of autoimmune activity. Her parathyroid hormone was elevated, the compensatory response to vitamin D deficiency that was driving the bone resorption responsible for her diffuse skeletal pain. Her inflammatory markers were raised, because vitamin D deficiency removes the anti-inflammatory regulatory function that adequate vitamin D provides across multiple immune pathways. Her cortisol pattern was dysregulated, a partial consequence of the chronic pain and poor sleep that profound vitamin D deficiency produces and perpetuates.
The FTO gene's relationship with vitamin D deficiency in Pakistani patients is one of the most clinically important and most consistently overlooked aspects of the Pakistani obesity metabolic profile. The FTO associated predisposition to visceral fat accumulation creates a self reinforcing vitamin D depletion cycle, visceral fat sequesters vitamin D, reducing its bioavailability and driving deficiency, while vitamin D deficiency worsens the insulin resistance and inflammatory environment that promotes further visceral fat accumulation. Pakistani patients with significant visceral obesity and the FTO associated metabolic profile are caught in this cycle from relatively early in their adult lives, entering a state of progressive vitamin D depletion that deepens with every kilogram of visceral fat gained and that worsens every other hormonal and metabolic disorder simultaneously.
We did not simply prescribe vitamin D supplements and send her home. We treated her vitamin D deficiency as the systemic hormonal emergency it represented, using high dose repletion protocols calibrated to her degree of deficiency and monitored to ensure adequate tissue restoration rather than merely numerical correction. We simultaneously addressed the insulin resistance that her vitamin D deficiency had been driving. We treated the autoimmune thyroid activity that her deficiency had been permitting. We corrected her parathyroid hormone elevation through vitamin D restoration and calcium optimisation. We reduced her visceral fat, removing the sequestration sink that had been depleting her vitamin D as fast as it could be replaced. We recalibrated her inflammatory environment and her cortisol pattern.
Ten months later her vitamin D was 94 nanomoles per litre, within the optimal range. Her insulin resistance had improved substantially. Her thyroid antibodies had fallen significantly. Her parathyroid hormone had normalised. Her bone pain had resolved almost completely. Her mood had lifted in a way she described as dramatic, the seasonal pattern had broken, the emotional fragility had resolved, the antidepressant she had been taking for two years had been tapered and discontinued under medical supervision because it was no longer necessary. She had lost 14 kilograms.
A vitamin level. Measuring one number had changed everything, not because vitamin D was the only driver of her condition but because its deficiency had been the keystone of a hormonal arch that was collapsing, and its restoration had allowed every other intervention to work with an effectiveness that would have been impossible in its absence.
FAQs
Pakistan receives substantial sunlight throughout the year, yet vitamin D deficiency is among the most prevalent nutritional deficiencies in the Pakistani population, affecting estimates of between sixty and ninety percent of Pakistani women in various studies. This paradox reflects the intersection of multiple simultaneous factors. Cultural and religious practices of skin coverage reduce sun exposure to the minimal areas that contribute meaningfully to vitamin D synthesis. Indoor lifestyles reduce the duration of that exposure further. Skin pigmentation in Pakistani patients requires substantially longer sun exposure than lighter skin to produce equivalent vitamin D. Dietary sources of vitamin D are minimal in traditional Pakistani cuisine. And visceral adiposity, extremely prevalent in Pakistani adults, sequesters vitamin D in fat tissue, reducing its bioavailability regardless of how much is produced or consumed. The result is a population living under intense sunlight in a state of profound vitamin D depletion.
Vitamin D deficiency drives weight gain through multiple simultaneous biological mechanisms that operate independently of caloric intake. It impairs insulin receptor expression and reduces pancreatic beta cell sensitivity to glucose, worsening insulin resistance and driving the compensatory hyperinsulinaemia that promotes visceral fat storage. It elevates parathyroid hormone compensatorily, and excess parathyroid hormone drives fat cell differentiation and lipid accumulation in adipocytes directly. It promotes the systemic inflammatory state that suppresses adiponectin production and impairs fat oxidation. It disrupts the serotonin and dopamine pathways that regulate appetite, mood, and food reward, increasing the likelihood of emotionally driven eating. And it impairs the muscle function that supports metabolic rate maintenance, reducing the lean tissue that burns energy at rest. A Pakistani patient with profound vitamin D deficiency is experiencing weight gain driven by hormonal mechanisms that no dietary restriction addresses.
The FTO gene at Chromosome 16q12.2 predisposes Pakistani patients to visceral fat accumulation at lower body weight thresholds than Western populations, and visceral fat is the primary sequestration site for fat soluble vitamin D. As visceral fat accumulates in FTO affected Pakistani patients, it acts as an expanding biological sink for vitamin D, absorbing and retaining the vitamin D produced from sun exposure and consumed from dietary sources, reducing its bioavailability in the circulation where it is needed for hormonal and metabolic function. This adipose sequestration creates a self reinforcing depletion cycle, visceral fat depletes vitamin D, vitamin D deficiency worsens insulin resistance, insulin resistance drives further visceral fat accumulation, and the expanding visceral fat sequesters more vitamin D. Breaking this cycle requires simultaneous vitamin D repletion and visceral fat reduction, which is precisely what THE CHROMOSOME protocol provides.
Vitamin D receptors are expressed in virtually every tissue in the human body, including the pancreas, thyroid, parathyroid glands, adrenal glands, ovaries, testes, pituitary, hypothalamus, and immune cells. Its deficiency therefore impairs the function of every one of these organs and systems simultaneously. It permits autoimmune dysregulation, removing the immune modulatory function that adequate vitamin D provides and allowing autoimmune thyroid disease, inflammatory joint disease, and systemic immune hyperactivity to proceed without modulation. It worsens insulin resistance, impairing the beta cell function and insulin receptor expression that adequate vitamin D supports. It elevates parathyroid hormone, driving bone resorption, kidney stone formation, and the metabolic consequences of calcium dysregulation. It suppresses testosterone production in men and disrupts ovarian function in women. And it impairs the cortisol regulatory function that adequate vitamin D supports in the adrenal glands. No single nutritional intervention in Pakistani obesity medicine has broader or more clinically significant downstream effects than vitamin D repletion.
Vitamin D exerts direct neuroactive effects in the brain, it regulates the synthesis of serotonin and dopamine, supports the function of the hypothalamic pituitary adrenal axis, modulates neuroinflammation, and maintains the integrity of neural circuits involved in mood regulation, motivation, and stress resilience. Its deficiency produces a neurological environment characterised by reduced serotonergic tone, contributing to the low mood, emotional fragility, and motivational flatness that Pakistani patients with profound vitamin D deficiency consistently describe. The seasonal pattern of mood worsening in winter, when sun exposure is reduced, and improvement in summer reflects this vitamin D serotonin relationship in its most clinically observable form. Pakistani patients prescribed antidepressants for low mood without vitamin D assessment are being treated for a neurochemical consequence without addressing the hormonal deficiency driving it, and antidepressants do not restore vitamin D.
Standard oral vitamin D supplementation at conventional doses, typically 1000 to 2000 international units daily, is frequently insufficient to correct profound vitamin D deficiency in Pakistani obesity patients for two reasons that standard prescribing practice does not account for. First, the degree of deficiency in Pakistani patients with visceral obesity is typically far more profound than conventional supplementation doses were designed to address, producing nominal improvements in circulating levels without achieving the tissue repletion that produces meaningful clinical benefit. Second, the adipose sequestration of vitamin D in visceral fat reduces the bioavailability of supplemented vitamin D, requiring higher doses and more prolonged supplementation to achieve adequate tissue saturation in obese patients than in lean individuals. Dr. Zaar uses repletion protocols calibrated to the individual's degree of deficiency, body composition, and biological response, monitoring levels to optimise tissue restoration rather than simply correcting the number on a laboratory report.
Severe vitamin D deficiency in Pakistani adults produces osteomalacia, a condition of impaired bone mineralisation in which adequate bone matrix is produced but cannot be mineralised normally due to insufficient calcium and phosphate availability. Osteomalacia produces the diffuse bone pain, muscle weakness, and skeletal fragility that Pakistani patients with profound vitamin D deficiency describe, a presentation distinct from the silent bone density loss of osteoporosis and one that is directly attributable to the vitamin D deficiency driving the mineralisation failure. Pakistani patients with this presentation are frequently diagnosed with fibromyalgia, arthritis, or musculoskeletal strain without the vitamin D assessment that would identify the nutritional hormonal origin of their symptoms. Vitamin D repletion resolves osteomalacic bone pain with a speed and completeness that no analgesic or anti-inflammatory medication achieves, because it treats the mineralisation failure rather than the pain it produces.
Standard Pakistani laboratory reference ranges classify vitamin D sufficiency at 50 nanomoles per litre or above, a threshold established in Western populations and reflecting the minimum level required to prevent rickets and osteomalacia rather than the level at which optimal immune function, insulin sensitivity, mood regulation, and hormonal health are supported. Emerging evidence and Dr. Zaar's clinical experience consistently support optimal vitamin D levels of between 100 and 150 nanomoles per litre for Pakistani obesity patients, a range at which the full spectrum of vitamin D's hormonal functions are supported and at which the metabolic and immune consequences of deficiency are most completely reversed. Achieving and maintaining this optimal range in Pakistani patients with visceral obesity requires individualised repletion protocols, regular monitoring, and simultaneous visceral fat reduction, because the adipose sequestration driving deficiency continues to operate until visceral fat is meaningfully reduced.